Acquisition - November 18, 2014
Recipharm Buys Lusomedicameta
The Swedish Pharmaceutical Contract Development and Manufacturing Organisation Recipharm AB (publ) has acquired Lisbon based CDMO Lusomedicameta Sociedade Técnica Farmacêutica S.A. for SEK 1 billion. The transaction values Lusomedicamenta at an enterprise value of EUR 112.3 million (SEK 1 040 million), which represents an adjusted EBITDA multiple of 8.8 based on LTM September 2014. The […]
Uncategorized - November 17, 2014
Beta Blockers Help Lesser-Known Heart Condition
Beta blockers may benefit individuals suffering from a little-known form of heart failure, called heart failure with preserved ejection fraction (HFPEF), which currently lacks well-established treatment, according to a press release from Sweden’s Karolinska Institutet. The findings are based on a registry study and are scheduled for publication in the Journal of the American Medical […]
Uncategorized - November 17, 2014
Benefits from Nordic, Stone Age Diets
A new Swedish study showed that a group of overweight, post-menopausal women who followed the Nordic Nutrition Recommendations lost as much weight as those who ate a Stone Age-inspired diet. A Swedish doctoral dissertation from Umeå University compared the effect of these two diet options for two years on 70 women. While those who followed […]
Clinical Trials - November 17, 2014
New Drug Delivery for Alzheimer’s
A team of scientists from San Francisco has found a way to transport medication to fight Alzheimer’s disease through the blood-brain barrier in monkeys without serious side-effects. A Danish PhD student who is participating on the research team, Maria Selch Hersom, from the Department of Pharmacology at the University of Copenhagen, noted that it has […]
Drug Development Pharma - November 14, 2014
AZ Developing Blood-Thinner Antidote
While sales of AstraZeneca’s blood-thinner Brilinta have been growing, the company has started a preclinical development program on a potential Brilinta antidote, now known as MEDI2452. If it works, the antidote could quickly reverse the effects of the blood thinner in an emergency, such as a person having a major bleeding episode. Doctors would not […]
Drug Development Pharma - November 14, 2014
New Dengue Vaccine Sought
Norwegian researchers are hoping to develop a plant-based vaccine for dengue fever, an often deadly disease on the rise in Asia. As was the case with the ZMapp Ebola medicine, the scientists are utilizing tobacco plants to develop antibodies. Developing new vaccines often is extremely costly and time-consuming, so researchers are eager to find easier […]
